FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273583359> ?p ?o ?g. }

• W2273583359 endingPage "228" @default.
• W2273583359 startingPage "222" @default.
• W2273583359 abstract "ABSTRACT Telavancin is a lipoglycopeptide with potent activity against methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA). The activity of telavancin against MRSA and MSSA after prior vancomycin exposure was studied in an in vitro pharmacodynamic model. Two clinical MRSA and two MSSA isolates, all with vancomycin MICs of 2 μg/ml, were subjected to humanized free drug exposures of vancomycin at 1 g every 12 h (q12h) for 96 h, telavancin at 750 mg q24h for 96 h, and vancomycin at 1 g q12h for 72 h followed by telavancin at 750 mg q24h for 48 h (120 h total). The microbiological responses were measured by changes from 0 h in log 10 CFU/ml at the end of experiments and area under the bacterial killing and regrowth curves over 96 h (AUBC 0−96 ). The control isolates grew to 8.8 ± 0.3 log 10 CFU/ml. Initially, all regimens caused −4.5 ± 0.9 reductions in log 10 CFU/ml by 48 h followed by slight regrowth over the following 48 to 72 h. After 96 h, vancomycin and telavancin achieved −3.7 ± 0.9 and −3.8 ± 0.8 log 10 CFU/ml changes from baseline, respectively ( P = 0.74). Sequential exposure to telavancin after vancomycin did not result in additional CFU reductions or increases, with ultimate log 10 CFU/ml reductions of −4.3 ± 1.1 at 96 h and −4.2 ± 1.3 at 120 h ( P > 0.05 for all comparisons at 96 h). The AUBC 0–96 was significantly smaller for the regimen of telavancin for 96 h than for the regimens of vancomycin for 96 h and vancomycin followed by telavancin ( P ≤ 0.04). No resistance was observed throughout the experiment. Against these MRSA and MSSA isolates with vancomycin MICs of 2 μg/ml, telavancin was comparable with vancomycin and its activity was unaffected by prior vancomycin exposure." @default.
• W2273583359 created "2016-06-24" @default.
• W2273583359 creator A5062302144 @default.
• W2273583359 creator A5088741251 @default.
• W2273583359 creator A5090657231 @default.
• W2273583359 date "2016-01-01" @default.
• W2273583359 modified "2023-09-27" @default.
• W2273583359 title "<i>In Vitro</i> Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure" @default.
• W2273583359 cites W1817362387 @default.
• W2273583359 cites W1959537530 @default.
• W2273583359 cites W1969798675 @default.
• W2273583359 cites W1983782613 @default.
• W2273583359 cites W1991605947 @default.
• W2273583359 cites W2000206960 @default.
• W2273583359 cites W2009886340 @default.
• W2273583359 cites W2010066166 @default.
• W2273583359 cites W2022372488 @default.
• W2273583359 cites W2062433729 @default.
• W2273583359 cites W2077228024 @default.
• W2273583359 cites W2078727847 @default.
• W2273583359 cites W2082816719 @default.
• W2273583359 cites W2093614132 @default.
• W2273583359 cites W2094260066 @default.
• W2273583359 cites W2096920028 @default.
• W2273583359 cites W2104267283 @default.
• W2273583359 cites W2106310886 @default.
• W2273583359 cites W2106559391 @default.
• W2273583359 cites W2108543270 @default.
• W2273583359 cites W2109063989 @default.
• W2273583359 cites W2116900840 @default.
• W2273583359 cites W2118726060 @default.
• W2273583359 cites W2119104982 @default.
• W2273583359 cites W2128184985 @default.
• W2273583359 cites W2133902131 @default.
• W2273583359 cites W2135123403 @default.
• W2273583359 cites W2137893923 @default.
• W2273583359 cites W2142167444 @default.
• W2273583359 cites W2144963218 @default.
• W2273583359 cites W2155139966 @default.
• W2273583359 cites W2163780760 @default.
• W2273583359 cites W2167031235 @default.
• W2273583359 cites W2256854376 @default.
• W2273583359 doi "https://doi.org/10.1128/aac.02033-15" @default.
• W2273583359 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4704209" @default.
• W2273583359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26482306" @default.
• W2273583359 hasPublicationYear "2016" @default.
• W2273583359 type Work @default.
• W2273583359 sameAs 2273583359 @default.
• W2273583359 citedByCount "3" @default.
• W2273583359 countsByYear W22735833592021 @default.
• W2273583359 countsByYear W22735833592022 @default.
• W2273583359 countsByYear W22735833592023 @default.
• W2273583359 crossrefType "journal-article" @default.
• W2273583359 hasAuthorship W2273583359A5062302144 @default.
• W2273583359 hasAuthorship W2273583359A5088741251 @default.
• W2273583359 hasAuthorship W2273583359A5090657231 @default.
• W2273583359 hasBestOaLocation W22735833591 @default.
• W2273583359 hasConcept C111113717 @default.
• W2273583359 hasConcept C112705442 @default.
• W2273583359 hasConcept C2777052132 @default.
• W2273583359 hasConcept C2778980435 @default.
• W2273583359 hasConcept C2779489039 @default.
• W2273583359 hasConcept C501593827 @default.
• W2273583359 hasConcept C523546767 @default.
• W2273583359 hasConcept C54355233 @default.
• W2273583359 hasConcept C71924100 @default.
• W2273583359 hasConcept C86803240 @default.
• W2273583359 hasConcept C89423630 @default.
• W2273583359 hasConcept C98274493 @default.
• W2273583359 hasConceptScore W2273583359C111113717 @default.
• W2273583359 hasConceptScore W2273583359C112705442 @default.
• W2273583359 hasConceptScore W2273583359C2777052132 @default.
• W2273583359 hasConceptScore W2273583359C2778980435 @default.
• W2273583359 hasConceptScore W2273583359C2779489039 @default.
• W2273583359 hasConceptScore W2273583359C501593827 @default.
• W2273583359 hasConceptScore W2273583359C523546767 @default.
• W2273583359 hasConceptScore W2273583359C54355233 @default.
• W2273583359 hasConceptScore W2273583359C71924100 @default.
• W2273583359 hasConceptScore W2273583359C86803240 @default.
• W2273583359 hasConceptScore W2273583359C89423630 @default.
• W2273583359 hasConceptScore W2273583359C98274493 @default.
• W2273583359 hasIssue "1" @default.
• W2273583359 hasLocation W22735833591 @default.
• W2273583359 hasLocation W22735833592 @default.
• W2273583359 hasLocation W22735833593 @default.
• W2273583359 hasLocation W22735833594 @default.
• W2273583359 hasOpenAccess W2273583359 @default.
• W2273583359 hasPrimaryLocation W22735833591 @default.
• W2273583359 hasRelatedWork W1834935829 @default.
• W2273583359 hasRelatedWork W2018382434 @default.
• W2273583359 hasRelatedWork W2099065614 @default.
• W2273583359 hasRelatedWork W2112338382 @default.
• W2273583359 hasRelatedWork W2125076516 @default.
• W2273583359 hasRelatedWork W2170374595 @default.
• W2273583359 hasRelatedWork W2326830576 @default.
• W2273583359 hasRelatedWork W2382345126 @default.
• W2273583359 hasRelatedWork W2565169118 @default.
• W2273583359 hasRelatedWork W4253170182 @default.

• next